-
1
-
-
11144355354
-
Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes
-
DOI 10.1056/NEJMoa040583
-
Cannon CP, Braunwald E, McCabe CH, et al. Intensive vs. moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 2004;350:1495-504 (Pubitemid 38477774)
-
(2004)
New England Journal of Medicine
, vol.350
, Issue.15
, pp. 1495-1504
-
-
Cannon, C.P.1
Braunwald, E.2
McCabe, C.H.3
Rader, D.J.4
Rouleau, J.L.5
Belder, R.6
Joyal, S.V.7
Hill, K.A.8
Pfeffer, M.A.9
Skene, A.M.10
-
2
-
-
4544243333
-
Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: Phase Z of the A to Z trial
-
DOI 10.1001/jama.292.11.1307
-
de Lemos JA, Blazing MA, Wiviott SD, et al. Early intensive versus a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial. JAMA 2004;292:1307-16 (Pubitemid 39223221)
-
(2004)
Journal of the American Medical Association
, vol.292
, Issue.11
, pp. 1307-1316
-
-
De Lemos, J.A.1
Blazing, M.A.2
Wiviott, S.D.3
Lewis, E.F.4
Fox, K.A.A.5
White, H.D.6
Rouleau, J.-L.7
Pedersen, T.R.8
Gardner, L.H.9
Mukherjee, R.10
Ramsey, K.E.11
Palmisano, J.12
Bilheimer, D.W.13
Pfeffer, M.A.14
Califf, R.M.15
Braunwald, E.16
-
3
-
-
15944410609
-
Intensive lipid lowering with atorvastatin in patients with stable coronary disease
-
DOI 10.1056/NEJMoa050461
-
LaRosa JC, Grundy SM, Waters DD, et al. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med 2005;352:1425-35 (Pubitemid 40471450)
-
(2005)
New England Journal of Medicine
, vol.352
, Issue.14
, pp. 1425-1435
-
-
LaRosa, J.C.1
Grundy, S.M.2
Waters, D.D.3
Shear, C.4
Barter, P.5
Fruchart, J.-C.6
Gotto, A.M.7
Greten, H.8
Kastelein, J.J.P.9
Shepherd, J.10
Wenger, N.K.11
-
4
-
-
27744603499
-
High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: The IDEAL study: A randomized controlled trial
-
DOI 10.1001/jama.294.19.2437
-
Pedersen TR, Faergeman O, Kastelein JJP, et al. High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction. The IDEAL Study: a randomized controlled trial. JAMA 2005;294:2437-45 (Pubitemid 41627921)
-
(2005)
Journal of the American Medical Association
, vol.294
, Issue.19
, pp. 2437-2445
-
-
Pedersen, T.R.1
Faergeman, O.2
Kastelein, J.J.P.3
Olsson, A.G.4
Tikkanen, M.J.5
Holme, I.6
Larsen, M.L.7
Bendiksen, F.S.8
Lindahl, C.9
Szarek, M.10
Tsai, J.11
-
5
-
-
23044493915
-
High-density lipoprotein cholesterol in the cardiovascular equation: Does the "good" still count?
-
Alsheikh-Ali AA, Kuvin JT, Karas RH. High-density lipoprotein cholesterol in the cardiovascular equation: does the "good" still count? Atherosclerosis 2005;180:217-23
-
(2005)
Atherosclerosis
, vol.180
, pp. 217-223
-
-
Alsheikh-Ali, A.A.1
Kuvin, J.T.2
Karas, R.H.3
-
6
-
-
26244432388
-
Efficacy and safety of cholesterol lowering treatment: Prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins
-
Baigent C, Keech A, Kearney PM, et al. Efficacy and safety of cholesterol lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 2005;366:1267-78
-
(2005)
Lancet
, vol.366
, pp. 1267-1278
-
-
Baigent, C.1
Keech, A.2
Kearney, P.M.3
-
7
-
-
57149144229
-
Lipid levels in patients hospitalized with coronary artery disease: An analysis of 136,905 hospitalizations in Get with the Guidelines
-
Sachdeva A, Cannon CP, Deedwania PC, et al. Lipid levels in patients hospitalized with coronary artery disease: an analysis of 136,905 hospitalizations in Get with the Guidelines. Am Heart J 2009;157:111-17
-
(2009)
Am Heart J
, vol.157
, pp. 111-117
-
-
Sachdeva, A.1
Cannon, C.P.2
Deedwania, P.C.3
-
8
-
-
35748972380
-
Prevalence of low high-density lipoprotein cholesterol in patients with documented coronary heart disease or risk equivalent and controlled low-density lipoprotein cholesterol
-
Alshejkh-Ali AA, Lin JL, Abourjally P, et al. Prevalence of low high-density lipoprotein cholesterol in patients with documented coronary heart disease or risk equivalent and controlled low-density lipoprotein cholesterol. Am J Cardiol 2007;100:1499-501
-
(2007)
Am J Cardiol
, vol.100
, pp. 1499-1501
-
-
Alshejkh-Ali, A.A.1
Lin, J.L.2
Abourjally, P.3
-
9
-
-
34748887666
-
HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events
-
DOI 10.1056/NEJMoa064278
-
Barter P, Gotto AM, LaRosa JC, et al. for the Treating to New Targets Investigators. HDL cholesterol, very low levels of LDL cholesterol and cardiovascular events. N Engl J Med 2007;357:1301-10 (Pubitemid 47481452)
-
(2007)
New England Journal of Medicine
, vol.357
, Issue.13
, pp. 1301-1310
-
-
Barter, P.1
Gotto, A.M.2
LaRosa, J.C.3
Maroni, J.4
Szarek, M.5
Grundy, S.M.6
Kastelein, J.J.P.7
Bittner, V.8
Fruchart, J.-C.9
-
10
-
-
37449021638
-
Clinical significance of high-density lipoprotein cholesterol in patients with low low-density lipoprotein cholesterol
-
deGoma EM, Leeper NJ, Heidenreich PA. Clinical significance of high-density lipoprotein cholesterol in patients with low low-density lipoprotein cholesterol. J Am Coll Cardiol 2008;51:49-55
-
(2008)
J Am Coll Cardiol
, vol.51
, pp. 49-55
-
-
DeGoma, E.M.1
Leeper, N.J.2
Heidenreich, P.A.3
-
11
-
-
4344665253
-
European Consensus Panel on HDL-C. Raising high-density lipoprotein cholesterol with reduction of cardiovascular risk: The role of nicotinic acid - A position paper developed by the European Consensus Panel on HDL-C
-
Chapman MJ, Assmann G, Fruchart JC, et al. European Consensus Panel on HDL-C. Raising high-density lipoprotein cholesterol with reduction of cardiovascular risk: the role of nicotinic acid - a position paper developed by the European Consensus Panel on HDL-C. Curr Med Res Opin 2004;20:1253-68
-
(2004)
Curr Med Res Opin
, vol.20
, pp. 1253-1268
-
-
Chapman, M.J.1
Assmann, G.2
Fruchart, J.C.3
-
12
-
-
44349114444
-
Targeting residual cardiovascular risk: Raising high-density lipoprotein cholesterol levels
-
DOI 10.1136/hrt.2007.125401
-
Hausenloy DJ, Yellon DM. Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels. Heart 2008;94:706-14 (Pubitemid 351744686)
-
(2008)
Heart
, vol.94
, Issue.6
, pp. 706-714
-
-
Hausenloy, D.J.1
Yellon, D.M.2
-
13
-
-
40749090434
-
Clinical presentation and outcomes of acute coronary syndromes in the Gulf Registry of Acute Coronary Events (Gulf RACE)
-
Zubaid M, Rashed WA, Al-Khaja N, et al. Clinical presentation and outcomes of acute coronary syndromes in the Gulf Registry of Acute Coronary Events (Gulf RACE). Saudi Med J 2008;29:251-5 (Pubitemid 351385128)
-
(2008)
Saudi Medical Journal
, vol.29
, Issue.2
, pp. 251-255
-
-
Zubaid, M.1
Rashed, W.A.2
Al-Khaja, N.3
Almahmeed, W.4
Al-Lawati, J.5
Sulaiman, K.6
Al-Motarreb, A.7
Amin, H.8
Al-Suwaidi, J.9
Al-Habib, K.10
-
14
-
-
0035195534
-
American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes: A report of the American College of Cardiology Task Force on Clinical Data Standards (Acute Coronary Syndromes Writing Committee)
-
DOI 10.1016/S0735-1097(01)01702-8, PII S0735109701017028
-
Cannon CP, Battler A, Brindis RG, et al. American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes. A report of the American College of Cardiology Task Force on Clinical Data Standards (Acute Coronary Syndromes Writing Committee). J Am Coll Cardiol 2001;38:2114-30 (Pubitemid 33116592)
-
(2001)
Journal of the American College of Cardiology
, vol.38
, Issue.7
, pp. 2114-2130
-
-
Cannon, C.P.1
Battler, A.2
Brindis, R.G.3
Cox, J.L.4
Ellis, S.G.5
Every, N.R.6
Flaherty, J.T.7
Harrington, R.A.8
Krumholz, H.M.9
Simoons, M.L.10
Van De, W.F.J.J.11
Weintraub, W.S.12
Mitchell, K.R.13
Morrisson, S.L.14
Brindis, R.G.15
Anderson, H.V.16
Cannom, D.S.17
Chitwood, J.W.R.18
Cigarroa, J.E.19
Collins-Nakai, R.L.20
Ellis, S.G.21
Gibbons, R.J.22
Grover, F.L.23
Heidenreich, P.A.24
Khandheria, B.K.25
Knoebel, S.B.26
Krumholz, H.L.27
Malenka, D.J.28
Mark, D.B.29
Mckay, C.R.30
Passamani, E.R.31
Radford, M.J.32
Riner, R.N.33
Schwartz, J.B.34
Shaw, R.E.35
Shemin, R.J.36
Van Fossen, D.B.37
Verrier, E.D.38
Watkins, M.W.39
Phoubandith, D.R.40
Furnelli, T.41
more..
-
15
-
-
27444443876
-
Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement
-
American Heart Association; National Heart, Lung, and Blood Institute
-
Grundy SM, Cleeman JI, Daniels SR, et al. American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005;112:2735-52
-
(2005)
Circulation
, vol.112
, pp. 2735-2752
-
-
Grundy, S.M.1
Cleeman, J.I.2
Daniels, S.R.3
-
16
-
-
70350245011
-
Harmonizing the Metabolic Syndrome A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention
-
National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity
-
Alberti KG, Eckel RH, Scott M, et al. Harmonizing the Metabolic Syndrome A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120:1640-5
-
(2009)
Circulation
, vol.120
, pp. 1640-1645
-
-
Alberti, K.G.1
Eckel, R.H.2
Scott, M.3
-
17
-
-
78249268245
-
More intensive lipid lowering is associated with regression of coronary atherosclerosis in diabetic patients with acute coronary syndrome
-
Arai H, Hiro T, Kimura T, et al. More intensive lipid lowering is associated with regression of coronary atherosclerosis in diabetic patients with acute coronary syndrome. J Atheroscler Thromb 2010;17:1096-107
-
(2010)
J Atheroscler Thromb
, vol.17
, pp. 1096-1107
-
-
Arai, H.1
Hiro, T.2
Kimura, T.3
-
18
-
-
33748043979
-
Impact of Low High-Density Lipoproteins on in-Hospital Events and One-Year Clinical Outcomes in Patients with Non-ST-Elevation Myocardial Infarction Acute Coronary Syndrome Treated with Drug-Eluting Stent Implantation
-
DOI 10.1016/j.amjcard.2006.04.006, PII S0002914906010599
-
Wolfram M, Brewer HB, Roswitha ZX, et al. Impact of low high-density lipoproteins on in hospital events and one-year clinical outcomes in patients with non-ST-elevation myocardial infarction acute coronary syndrome treated with drug-eluting stent implantation. Am J Cardiol 2006;98:711-17 (Pubitemid 44300998)
-
(2006)
American Journal of Cardiology
, vol.98
, Issue.6
, pp. 711-717
-
-
Wolfram, R.M.1
Brewer, H.B.2
Xue, Z.3
Satler, L.F.4
Pichard, A.D.5
Kent, K.M.6
Waksman, R.7
-
19
-
-
58749101341
-
Relation of high-density lipoprotein cholesterol to mortality after percutaneous coronary interventions in patients with low-density lipoprotein <70 mg/dl
-
Kini AS, Muntner P, Moreno PR, et al. Relation of high-density lipoprotein cholesterol to mortality after percutaneous coronary interventions in patients with low-density lipoprotein <70 mg/dl. Am J Cardiol 2009;103:350-4
-
(2009)
Am J Cardiol
, vol.103
, pp. 350-354
-
-
Kini, A.S.1
Muntner, P.2
Moreno, P.R.3
-
20
-
-
4444222221
-
Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults
-
DOI 10.1161/01.CIR.0000140677.20606.0E
-
Malik S, Wong ND, Franklin SS, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 2004;110:1245-50 (Pubitemid 39202340)
-
(2004)
Circulation
, vol.110
, Issue.10
, pp. 1245-1250
-
-
Malik, S.1
Wong, N.D.2
Franklin, S.S.3
Kamath, T.V.4
L'Italien, G.J.5
Pio, J.R.6
Williams, G.R.7
-
21
-
-
0037021505
-
The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men
-
DOI 10.1001/jama.288.21.2709
-
Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular mortality in middle-aged men. JAMA 2002;288:2709-16 (Pubitemid 35403784)
-
(2002)
Journal of the American Medical Association
, vol.288
, Issue.21
, pp. 2709-2716
-
-
Lakka, H.-M.1
Laaksonen, D.E.2
Lakka, T.A.3
Niskanen, L.K.4
Kumpusalo, E.5
Tuomilehto, J.6
Salonen, J.T.7
-
22
-
-
79952652068
-
Prevalence, characteristics, and in-hospital outcomes of metabolic syndrome among acute coronary syndrome patients from Oman
-
in press
-
Al-Rasadi K, Sulaiman K, Panduranga P, et al. Prevalence, characteristics, and in-hospital outcomes of metabolic syndrome among acute coronary syndrome patients from Oman. Angiology 2010; in press
-
(2010)
Angiology
-
-
Al-Rasadi, K.1
Sulaiman, K.2
Panduranga, P.3
-
23
-
-
27744603554
-
Reducing residual risk for patients on statin therapy: The potential role of combination therapy
-
Discussion 34-35K
-
Davidson MH: Reducing residual risk for patients on statin therapy: the potential role of combination therapy. Am J Cardiol 2005;96:3-13K. Discussion 34-35K
-
(2005)
Am J Cardiol
, vol.96
-
-
Davidson, M.H.1
-
24
-
-
33746428470
-
For the Treating to New Targets Investigators. Effect of lowering LDL cholesterol substantially below currently recommended levels in patients with coronary heart disease and diabetes: The Treating to New Targets (TNT) study
-
Shepherd J, Barter P, Carmena R, et al. for the Treating to New Targets Investigators. Effect of lowering LDL cholesterol substantially below currently recommended levels in patients with coronary heart disease and diabetes: the Treating to New Targets (TNT) study. Diabetes Care 2006;29:1220-6
-
(2006)
Diabetes Care
, vol.29
, pp. 1220-1226
-
-
Shepherd, J.1
Barter, P.2
Carmena, R.3
-
25
-
-
44649096384
-
Multiple actions of high-density lipoprotein
-
DOI 10.1097/HCO.0b013e3283043806, PII 0000157320080700000015
-
Florentin M, Liberopoulos EN, Wierzbicki AS, et al. Multiple actions of high-density lipoprotein. Curr Opin Cardiol 2008;23:370-8 (Pubitemid 351787103)
-
(2008)
Current Opinion in Cardiology
, vol.23
, Issue.4
, pp. 370-378
-
-
Florentin, M.1
Liberopoulos, E.N.2
Wierzbicki, A.S.3
Mikhailidis, D.P.4
-
26
-
-
54149106537
-
Patterns and prognostic implications of low high-density lipoprotein levels in patients with non-ST-segment elevation acute coronary syndromes
-
Roe MT, Ou FS, Alexander KP, et al. Patterns and prognostic implications of low high-density lipoprotein levels in patients with non-ST-segment elevation acute coronary syndromes. Eur Heart J 2008;29:2480-8
-
(2008)
Eur Heart J
, vol.29
, pp. 2480-2488
-
-
Roe, M.T.1
Ou, F.S.2
Alexander, K.P.3
-
27
-
-
77954924983
-
A very high prevalence of low HDL cholesterol in Spanish patients with acute coronary syndromes
-
Pintó X, Millán J, Muñoz AA, et al. A very high prevalence of low HDL cholesterol in Spanish patients with acute coronary syndromes. Clin Cardiol 2010;33:418-23
-
(2010)
Clin Cardiol
, vol.33
, pp. 418-423
-
-
Pintó, X.1
Millán, J.2
Muñoz, A.A.3
-
28
-
-
44649143930
-
Acute effects of high-density lipoproteins: Biochemical basis and clinical findings
-
DOI 10.1097/HCO.0b013e3283007ccd, PII 0000157320080700000016
-
Chiesa G, Parolini C, Sirtori CR. Acute effects of high-density lipoproteins: biochemical basis and clinical findings. Curr Opin Cardiol 2008;23:379-85 (Pubitemid 351787104)
-
(2008)
Current Opinion in Cardiology
, vol.23
, Issue.4
, pp. 379-385
-
-
Chiesa, G.1
Parolini, C.2
Sirtori, C.R.3
-
29
-
-
33846863146
-
Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis
-
DOI 10.1001/jama.297.5.499
-
Nicholls SJ, Tuzcu EM, Sipahi I, et al. Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis. JAMA 2007;297:499-508 (Pubitemid 46220805)
-
(2007)
Journal of the American Medical Association
, vol.297
, Issue.5
, pp. 499-508
-
-
Nicholls, S.J.1
Tuzcu, E.M.2
Sipahi, I.3
Grasso, A.W.4
Schoenhagen, P.5
Hu, T.6
Wolski, K.7
Crowe, T.8
Desai, M.Y.9
Hazen, S.L.10
Kapadia, S.R.11
Nissen, S.E.12
-
30
-
-
34547655744
-
ACC/AHA 2007 Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction
-
Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction. J Am Coll Cardiol 2007;50:e1-157
-
(2007)
J Am Coll Cardiol
, vol.50
-
-
Anderson, J.L.1
Adams, C.D.2
Antman, E.M.3
-
31
-
-
3142729178
-
Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines
-
National Heart, Lung, Blood Institute; American College of Cardiology Foundation; American Heart Association
-
Grundy SM, Cleeman JI, Merz CNB, et al. National Heart, Lung, Blood Institute; American College of Cardiology Foundation; American Heart Association. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004;110:227-39
-
(2004)
Circulation
, vol.110
, pp. 227-239
-
-
Grundy, S.M.1
Cleeman, J.I.2
Merz, C.N.B.3
-
32
-
-
70350360003
-
Canadian Cardiovascular Society/ Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult - 2009
-
Genest J, McPherson R, Frohlich J, et al. Canadian Cardiovascular Society/ Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult - 2009. Can J Cardiol 2009;25:567-79
-
(2009)
Can J Cardiol
, vol.25
, pp. 567-579
-
-
Genest, J.1
McPherson, R.2
Frohlich, J.3
-
33
-
-
0032935707
-
Upregulation of cholesterol synthesis after acute myocardial infarction is cholesterol a positive acute phase reactant?
-
Pfohl M, Schreiber I, Liebich HM, et al. Upregulation of cholesterol synthesis after acute myocardial infarction is cholesterol a positive acute phase reactant? Atherosclerosis 1999;142:389-93
-
(1999)
Atherosclerosis
, vol.142
, pp. 389-393
-
-
Pfohl, M.1
Schreiber, I.2
Liebich, H.M.3
-
34
-
-
41549153243
-
Lipid Levels after Acute Coronary Syndromes
-
DOI 10.1016/j.jacc.2007.11.075, PII S0735109708003914
-
Pitt B, Loscalzo J, Ycas J, et al. Lipid levels after acute coronary syndromes. J Am Coll Cardiol 2008;51:1440-5 (Pubitemid 351470033)
-
(2008)
Journal of the American College of Cardiology
, vol.51
, Issue.15
, pp. 1440-1445
-
-
Pitt, B.1
Loscalzo, J.2
Ycas, J.3
Raichlen, J.S.4
-
35
-
-
79953867783
-
Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: Systemic review and meta-regression analysis
-
Briel M, Ferreira-Gonzalez I, You JJ, et al. Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systemic review and meta-regression analysis. BMJ 2009;338:b92
-
(2009)
BMJ
, vol.338
-
-
Briel, M.1
Ferreira-Gonzalez, I.2
You, J.J.3
-
36
-
-
78751640788
-
Meta-analysis: Statin therapy does not alter the association between low levels of high-density lipoprotein cholesterol and increased cardiovascular risk
-
Jaafri H, Alsheikh-Ali A, Karas RH. Meta-analysis: Statin therapy does not alter the association between low levels of high-density lipoprotein cholesterol and increased cardiovascular risk. Ann Intern Med 2010;153:800-8
-
(2010)
Ann Intern Med
, vol.153
, pp. 800-808
-
-
Jaafri, H.1
Alsheikh-Ali, A.2
Karas, R.H.3
|